{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:47:12Z","timestamp":1776185232659,"version":"3.50.1"},"reference-count":108,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Extensive coronary artery disease whether at initial presentation or after percutaneous coronary intervention (PCI), involves the use of dual antiplatelet therapy (DAPT) as a very significant therapeutic option. There are many reasons why clinicians should weigh the risks of bleeding and cardiovascular thrombosis when deciding whether to maintain or discontinue DAPT in such patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This comprehensive review systematically analyzed via electronic databases, a total of 39 papers most of which were on countries in Southeast Asia. The focus was on randomized control designs (RCTs) and observational studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results and discussion:<\/jats:title>\n                    <jats:p>PCI with drug eluting stents was the most common method of treating acute coronary syndrome. The study found more independent predictors of gastrointestinal (GI) bleeding in young and elderly patients from Southeast Asia. The precise DAPT score was more readily used among various bleeding risk prediction models for patients on antiplatelet therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The use of DAPT in the setting of the GI bleeding risk in patients with coronary artery disease has been studied extensively, but there are still no clearly defined strategies and very definite answers to the risk of bleeding versus cardiac event envisaged during the management of an extensive acute coronary disease mostly in southeast Asia. More studies using good study designs and statistics and establishing clinical prediction rules, are needed to fill this knowledge gap most especially in Southeast Asia and Middle East.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ms9.0000000000002833","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T06:00:07Z","timestamp":1734674407000},"page":"3715-3735","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Dual antiplatelet therapy in GI-bleed patients with extensive coronary artery disease history: a systematic review"],"prefix":"10.1097","volume":"87","author":[{"given":"Abdulrashid","family":"Onimisi Abdulrahim","sequence":"first","affiliation":[{"name":"Gastroenterology Specialist. Fellowship NPMCN, King Fahd Specialist Hospital Buraydah, Al Qassim province, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohannad Jawad","family":"Yahya Abd-Alhadi","sequence":"additional","affiliation":[{"name":"AbdulHadi Hospital, Amman, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein Attia","family":"Hussein Mahmoud","sequence":"additional","affiliation":[{"name":"Diagnostic Radiology Fellowship Heliopolis Hospital, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Sarwar","sequence":"additional","affiliation":[{"name":"Dr. V.R.K. Women\u2019s Medical College, Hyderabad, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anum","family":"Akram","sequence":"additional","affiliation":[{"name":"Jinnah Sindh Medical University Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter Jauregui","family":"Alvarado","sequence":"additional","affiliation":[{"name":"Universidad Nacional Auto\u0301noma de Honduras, Tegucigalpa, Honduras"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olamide","family":"Sadik","sequence":"additional","affiliation":[{"name":"Richmond Gabriel University, St. Vincent and the Grenadines"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srija Reddy","family":"Kesireddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2881-2556","authenticated-orcid":false,"given":"Hassan","family":"Mumtaz","sequence":"additional","affiliation":[{"name":"SVS Medical College, Mahabubnagar, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"R1-20251204","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5492\/wjccm.v4.i1.40","article-title":"Treatment and prevention of gastrointestinal bleeding in patients receiving antiplatelet therapy","volume":"4","author":"Yasuda","year":"2015","journal-title":"World J Crit Care Med"},{"key":"R2-20251204","doi-asserted-by":"crossref","first-page":"B1","DOI":"10.1093\/eurheartj\/sux041","article-title":"Bleeding on dual antiplatelet therapy: real-life challenges","volume":"20","author":"Deshpande","year":"2018","journal-title":"Eur Heart J"},{"key":"R3-20251204","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.3390\/jcm11133574","article-title":"Risk scores of bleeding complications in patients on dual antiplatelet therapy: how to optimize identification of patients at risk of bleeding after percutaneous coronary intervention","volume":"11","author":"Pelliccia","year":"2022","journal-title":"J Clin Med"},{"key":"R4-20251204","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s11239-013-0899-7","article-title":"Assessing bleeding risk in patients taking anticoagulants","volume":"35","author":"Shoeb","year":"2013","journal-title":"J Thromb Thrombolysis"},{"key":"R5-20251204","doi-asserted-by":"crossref","first-page":"571605","DOI":"10.3389\/fphar.2020.571605","article-title":"A new score for predicting acute gastrointestinal bleeding in patients administered oral antiplatelet drugs","volume":"11","author":"Lv","year":"2021","journal-title":"Front Pharmacol"},{"key":"R6-20251204","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0140-6736(17)30770-5","article-title":"Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study","volume":"390","author":"Li","year":"2017","journal-title":"Lancet"},{"key":"R7-20251204","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s11739-021-02672-5","article-title":"Safety of antithrombotic therapy in East Asian patients","volume":"16","author":"Goto","year":"2021","journal-title":"Intern Emerg Med"},{"key":"R8-20251204","doi-asserted-by":"crossref","first-page":"e008708","DOI":"10.1161\/JAHA.118.008708","article-title":"Prediction of thrombotic and bleeding events after percutaneous coronary intervention: CREDO-Kyoto thrombotic and bleeding risk scores","volume":"7","author":"Natsuaki","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"R9-20251204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15420\/ecr.2019.09","article-title":"Dual antiplatelet therapy in coronary artery disease: comparison between ACC\/AHA 2016 and ESC 2017 guidelines","volume":"15","author":"Floyd","year":"2020","journal-title":"Eur Cardiol"},{"key":"R10-20251204","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.gie.2007.11.037","article-title":"Korean association for the study of intestinal disease. Managing anticoagulation and antiplatelet medications in GI endoscopy: a survey comparing the East and the West","volume":"67","author":"Lee","year":"2008","journal-title":"Gastrointest Endosc"},{"key":"R12-20251204","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/eurheartj\/ehac706","article-title":"Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials","volume":"44","author":"Costa","year":"2023","journal-title":"Eur Heart J"},{"key":"R13-20251204","first-page":"365","article-title":"Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis","volume":"1","author":"Xu","year":"2019","journal-title":"BMJ"},{"key":"R14-20251204","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/jgh.13712","article-title":"East Asian perspective on the interaction between proton pump inhibitors and clopidogrel","volume":"32","author":"Zou","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"R15-20251204","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1370\/afm.2734","article-title":"Barriers to guideline-based use of proton pump inhibitors to prevent upper gastrointestinal bleeding","volume":"20","author":"Kurlander","year":"2022","journal-title":"Ann Family Med"},{"key":"R16-20251204","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2125.2011.03943.x","article-title":"Antiplatelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual antiplatelet therapy","volume":"72","author":"Warner","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"R17-20251204","doi-asserted-by":"crossref","first-page":"143","DOI":"10.20452\/pamw.911","article-title":"Antiplatelet therapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. Key messages for clinical practice","volume":"120","author":"Leontiadis","year":"2010","journal-title":"Pol Arch Med Wewn"},{"key":"R18-20251204","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ehj.2003.10.013","article-title":"ESC Committee for Practice Guidelines (CPG), document reviewers, expert consensus document on the use of antiplatelet agents: the task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology","volume":"25","author":"Patrono","year":"2004","journal-title":"Eur Heart J"},{"key":"R19-20251204","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.3390\/jcm9072064","article-title":"Acute coronary syndrome, antiplatelet therapy, and bleeding: a clinical perspective","volume":"9","author":"Tersalvi","year":"2020","journal-title":"J Clin Med"},{"key":"R20-20251204","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ijcard.2010.12.081","article-title":"Incidence, predictors and outcome of upper gastrointestinal bleeding in patients with acute coronary syndromes","volume":"157","author":"Shalev","year":"2012","journal-title":"Int J Cardiol"},{"key":"R21-20251204","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1186\/s13063-022-06464-w","article-title":"Proton pump inhibitor in the prevention of upper gastrointestinal mucosal injury associated with dual antiplatelet therapy after coronary artery bypass grafting (DACAB-GI-2): study protocol for a randomized controlled trial","volume":"23","author":"Zhu","year":"2022","journal-title":"Trials"},{"key":"R22-20251204","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2036.2006.02759.x","article-title":"Upper gastrointestinal bleeding associated with antiplatelet drugs","volume":"23","author":"Ib\u00e1\u00f1ez","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R23-20251204","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1097\/MCG.0b013e3181faec3c","article-title":"Incidence, predictors, and outcomes of gastrointestinal bleeding in patients on dual antiplatelet therapy with aspirin and clopidogrel","volume":"45","author":"Alli","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"R24-20251204","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jcma.2012.09.004","article-title":"Risk factors for upper gastrointestinal bleeding in coronary artery disease patients receiving both aspirin and clopidogrel","volume":"76","author":"Huang","year":"2013","journal-title":"J Chin Med Assoc"},{"key":"R25-20251204","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000321813","article-title":"Gastrointestinal bleeding after percutaneous coronary intervention","volume":"83","author":"Tanigawa","year":"2011","journal-title":"Digestion"},{"key":"R26-20251204","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.clinre.2013.03.011","article-title":"Proton-pump inhibitors can decrease gastrointestinal bleeding after percutaneous coronary intervention","volume":"37","author":"Jiang","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R27-20251204","doi-asserted-by":"crossref","first-page":"661619","DOI":"10.3389\/fphar.2021.661619","article-title":"Incidence and risk factors for antiplatelet therapy-related bleeding complications among elderly patients after coronary stenting: a multicenter retrospective observation","volume":"12","author":"Qian","year":"2021","journal-title":"Front Pharmacol"},{"issue":"8","key":"R28-20251204","doi-asserted-by":"crossref","first-page":"645","DOI":"10.4070\/kcj.2020.0098","article-title":"Ethnic differences in oral antithrombotic therapy","volume":"50","author":"Cho","year":"2020","journal-title":"Korean Circ J"},{"key":"R29-20251204","doi-asserted-by":"crossref","first-page":"ehab724","DOI":"10.1093\/eurheartj\/ehab724.3001","article-title":"Differences of gastrointestinal bleeding after percutaneous coronary intervention with stent implantation among the different dual anti platelet therapies","volume":"42","author":"Idiazabal","year":"2021","journal-title":"Eur Heart J"},{"key":"R30-20251204","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.amjcard.2005.06.056","article-title":"Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes","volume":"96","author":"Rao","year":"2005","journal-title":"Am J Cardiol"},{"key":"R31-20251204","doi-asserted-by":"crossref","first-page":"542","DOI":"10.14309\/ajg.0000000000001627","article-title":"American College of Gastroenterology-Canadian Association of Gastroenterology clinical practice guideline: management of anticoagulants andantiplatelets during acute gastrointestinal bleeding and the peri endoscopic period","volume":"117","author":"Abraham","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"R32-20251204","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/gutjnl-2017-315131","article-title":"Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines","volume":"67","author":"Chan","year":"2018","journal-title":"Gut"},{"key":"R33-20251204","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4236\/wjcd.2018.810046","article-title":"Risk factors for gastrointestinal injuries in acute coronary syndrome patients with double antiplatelet therapy in one-year follow-up","volume":"8","author":"Zhong","year":"2018","journal-title":"World J Cardiovasc Dis"},{"key":"R34-20251204","doi-asserted-by":"crossref","first-page":"e21312","DOI":"10.1097\/MD.0000000000021312","article-title":"Prediction of gastrointestinal bleeding events in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an observational cohort study (STROBE compliant)","volume":"99","author":"Zheng","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R35-20251204","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5009\/gnl14127","article-title":"Clinical risk factors for upper gastrointestinal bleeding after percutaneous coronary intervention: a single-center study","volume":"10","author":"Lee","year":"2016","journal-title":"Gut Liver"},{"key":"R36-20251204","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10654-009-9319-x","article-title":"Ex-drinking may be a surrogate for unmeasured risk factors for upper gastrointestinal bleeding: reappraisal and an additional survey of subjects from a case\u2013control study in Japan","volume":"24","author":"Watanabe","year":"2009","journal-title":"Eur J Epidemiol"},{"key":"R37-20251204","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1159\/000494543","article-title":"Predictors and management of antiplatelet-related bleeding complications for acute coronary syndrome in Chinese elderly patients","volume":"50","author":"Wan","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"R38-20251204","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jacc.2009.07.019","article-title":"Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy)","volume":"54","author":"Nikolsky","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R39-20251204","doi-asserted-by":"crossref","first-page":"e002053","DOI":"10.1161\/CIRCINTERVENTIONS.114.002053","article-title":"Clinical impact of gastrointestinal bleeding in patients undergoing percutaneous coronary interventions","volume":"8","author":"Koskinas","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"R40-20251204","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/MEG.0000000000001125","article-title":"Reduction in post percutaneous coronary intervention angina in addition to gastrointestinal events in patients on combined proton pump inhibitors and dual antiplatelet therapy: a systematic review and meta-analysis","volume":"30","author":"Khan","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R41-20251204","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000489165","article-title":"H2 receptor antagonists versus proton pump inhibitors in patients on dual antiplatelet therapy for coronary artery disease: a systematic review","volume":"140","author":"Al Mufleh","year":"2018","journal-title":"Cardiology"},{"issue":"5","key":"R42-20251204","doi-asserted-by":"crossref","first-page":"630","DOI":"10.21037\/cdt.2018.10.01","article-title":"The optimal duration of dual antiplatelet therapy after coronary stent implantation: to go too far is as bad as to fall short","volume":"8","author":"Costa","year":"2018","journal-title":"Cardiovasc Diagn Ther"},{"key":"R43-20251204","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.26442\/00403660.2021.12.201224","article-title":"Gastric mucosa condition in patients with coronary artery disease and high risk of gastrointestinal bleeding (register REGATTA-1)","volume":"93","author":"Komarov","year":"2021","journal-title":"Terapevticheskii Arkhiv"},{"key":"R44-20251204","first-page":"846","article-title":"Low-dose aspirin for primary prevention of cardiovascular events comparing East Asians with Westerners: a meta-analysis","volume":"3","author":"Bum Kim","year":"2023","journal-title":"JACC: Asia"},{"key":"R45-20251204","doi-asserted-by":"crossref","first-page":"537","DOI":"10.4070\/kcj.2018.0166","article-title":"The evolving concept of dual antiplatelet therapy after percutaneous coronary intervention: focus on unique feature of East Asian and \u201cAsian paradox\u201d","volume":"48","author":"Kang","year":"2018","journal-title":"Korean Circ J"},{"key":"R46-20251204","article-title":"Dual antiplatelet therapy following percutaneous coronary intervention: clinical and economic impact of standard versus extended duration","author":"Wells","journal-title":"Canada\u2019s Drug Agency"},{"key":"R47-20251204","first-page":"551","article-title":"Bleeding academic research consortium consensus report","volume":"123","author":"Hicks","year":"2011","journal-title":"Food Drug Admin"},{"key":"R48-20251204","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1161\/CIRCULATIONAHA.122.062770","article-title":"Aspirin versus clopidogrel for long-term maintenance monotherapy after percutaneous coronary intervention: the HOSTEXAM extended study","volume":"147","author":"Kang","year":"2023","journal-title":"Circulation"},{"key":"R49-20251204","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/S0140-6736(21)01063-1","article-title":"HOST-EXAM investigators. Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOSTEXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial","volume":"397","author":"Koo","year":"2021","journal-title":"Lancet"},{"key":"R50-20251204","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","article-title":"COGENT Investigators. Clopidogrel with or without omeprazole in coronary artery disease","volume":"363","author":"Bhatt","year":"2010","journal-title":"N Engl J Med"},{"key":"R51-20251204","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/heartjnl-2012-301632","article-title":"Lower GI bleeding is more common than upper among patients on dual antiplatelet therapy: long-term follow-up of a cohort of patients commonly using PPI co-therapy","volume":"98","author":"Casado Arroyo","year":"2012","journal-title":"Heart"},{"key":"R52-20251204","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.gie.2014.06.039","article-title":"Lower GI bleeding risk of nonsteroidal anti-inflammatory drugs and antiplatelet drug use alone and the effect of combined therapy","volume":"80","author":"Nagata","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"R53-20251204","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/heartjnl-2016-310090","article-title":"TRILOGY ACS Investigators. Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes","volume":"103","author":"Alfredsson","year":"2017","journal-title":"Heart"},{"key":"R54-20251204","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4103\/1319-3767.182452","article-title":"Outcome of acute upper gastrointestinal bleeding in patients with coronary artery disease: a matched case control study","volume":"22","author":"Thanapirom","year":"2016","journal-title":"Saudi J Gastroenterol"},{"key":"R55-20251204","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1038\/s41598-022-09911-5","article-title":"Randomized controlled trial of early endoscopy for upper gastrointestinal bleeding in acute coronary syndrome patients","volume":"12","author":"Chung","year":"2022","journal-title":"Sci Rep"},{"key":"R56-20251204","first-page":"109","article-title":"In-hospital gastrointestinal bleeding following percutaneous coronary intervention","volume":"95","author":"Kwok","year":"2020","journal-title":"Catheterization Cardiovasc Interv"},{"key":"R57-20251204","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1212\/WNL.0b013e3181eee40f","article-title":"Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy","volume":"75","author":"Biffi","year":"2010","journal-title":"Neurology"},{"issue":"8","key":"R58-20251204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/MNJY9014","article-title":"Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies","volume":"27","author":"Harris","year":"2023","journal-title":"Health Technol Assess"},{"key":"R59-20251204","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(13)61615-3","article-title":"Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data","volume":"382","author":"Steg","year":"2013","journal-title":"Lancet"},{"key":"R60-20251204","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/CIRCULATIONAHA.108.813667","article-title":"Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents","volume":"119","author":"Eisenberg","year":"2009","journal-title":"Circulation"},{"key":"R61-20251204","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1053\/j.gastro.2018.10.036","article-title":"Risk of postpolypectomy bleeding with uninterrupted clopidogrel therapy in an industry-independent, double-blind, randomized trial","volume":"156","author":"Chan","year":"2019","journal-title":"Gastroenterology"},{"key":"R62-20251204","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"R63-20251204","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.gie.2020.01.039","article-title":"Nonvariceal upper GI haemorrhage after percutaneous coronary intervention for acute myocardial infarction: a national analysis over 11 months","volume":"92","author":"Bilal","year":"2020","journal-title":"Clin Gastrointest Endosc"},{"key":"R64-20251204","doi-asserted-by":"crossref","first-page":"899","DOI":"10.14309\/ajg.0000000000001245","article-title":"ACG clinical guideline: upper gastrointestinal and ulcer bleeding","volume":"116","author":"Laine","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"R65-20251204","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4253\/wjge.v11.i2.68","article-title":"Role of endoscopy in acute gastrointestinal bleeding in real clinical practice: an evidence-based review","volume":"11","author":"Jung","year":"2019","journal-title":"World J Gastrointest Endosc"},{"key":"R66-20251204","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.gie.2012.01.011","article-title":"Appropriate use of GI endoscopy","volume":"75","author":"Early","year":"2012","journal-title":"Gastrointest Endosc"},{"key":"R67-20251204","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.gie.2012.02.033","article-title":"Standards of practice committee of the American society for gastrointestinal endoscopy. The role of endoscopy in the management of acute nonvariceal upper GI bleeding","volume":"75","author":"Hwang","year":"2012","journal-title":"Gastrointest Endosc"},{"key":"R68-20251204","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/apt.15441","article-title":"Risk of rebleeding, vascular events and death after gastrointestinal bleeding in anticoagulant and\/or antiplatelet users","volume":"50","author":"Sostres","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"R69-20251204","doi-asserted-by":"crossref","first-page":"0016","DOI":"10.1016\/j.gie.2020.03.012","article-title":"The challenge of non-variceal upper GI bleeding management in patients with acute coronary syndrome receiving Dual antiplatelet therapy","volume":"92","author":"Salltzman","year":"2020","journal-title":"Gastrointest Endosc"},{"key":"R70-20251204","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jjcc.2014.12.008","article-title":"Major adverse cardiac and bleeding events associated with non-cardiac surgery in coronary artery disease patients with or without prior percutaneous coronary intervention","volume":"66","author":"Wakabayashi","year":"2015","journal-title":"J Cardiol"},{"key":"R71-20251204","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1161\/CIRCRESAHA.114.302737","article-title":"Antiplatelet and anticoagulation therapy for acute coronary syndromes","volume":"114","author":"Bhatt","year":"2014","journal-title":"Circ Res"},{"key":"R72-20251204","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1177\/2047487320937846","article-title":"Predictive ability of longitudinal changes in PRECISE-DAPT score in patients on dual antiplatelet therapy: the RESCORE multicentre prospective registry","volume":"28","author":"Pelliccia","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"R73-20251204","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1182\/hematology.2020000151","article-title":"Combining antiplatelet and anticoagulant therapy in cardiovascular disease","volume":"2020","author":"Barnes","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R74-20251204","first-page":"E518","article-title":"Radial vs femoral access for the prevention of acute kidney injury (AKI) after coronary angiography or intervention: a systematic review and meta-analysis","volume":"92","author":"And\u00f2","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"R75-20251204","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2174\/1570161116666180117103238","article-title":"Should antithrombotic treatment strategies in East Asians differ from Caucasians?","volume":"16","author":"Bae","year":"2018","journal-title":"Curr Vasc Pharmacol"},{"key":"R76-20251204","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/gutjnl-2021-325184","article-title":"Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update","volume":"70","author":"Veitch","year":"2021","journal-title":"Gut"},{"key":"R77-20251204","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.jacc.2012.02.042","article-title":"Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trial","volume":"59","author":"Price","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R78-20251204","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cpt.1616","article-title":"Differential effects of ticagrelor with or without aspirin on platelet reactivity and coagulation activation: a randomized trial in healthy volunteers","volume":"107","author":"Traby","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"R79-20251204","first-page":"2510","article-title":"Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial","volume":"310","author":"Feres","year":"2013","journal-title":"JAMA"},{"key":"R80-20251204","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"R81-20251204","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jacc.2018.11.048","article-title":"PRECISE-DAPT study investigators. dual antiplatelet therapy duration based on ischemic and bleeding risks after coronary stenting","volume":"73","author":"Costa","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R82-20251204","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/eurheartj\/ehad728","article-title":"What is the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention in high-bleeding risk: 1 month or 3 months?","volume":"45","author":"Zhao","year":"2024","journal-title":"Eur Heart J"},{"key":"R83-20251204","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12471-018-1113-5","article-title":"Optimal duration of dual antiplatelet therapy for coronary artery disease","volume":"26","author":"Kikkert","year":"2018","journal-title":"Neth Heart J"},{"key":"R84-20251204","doi-asserted-by":"crossref","first-page":"111639","DOI":"10.1016\/j.jacc.2016.03.512","article-title":"Duration of dual antiplatelet therapy: a systematic review for the 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"68","author":"Bittl","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R85-20251204","doi-asserted-by":"crossref","first-page":"h1618","DOI":"10.1136\/bmj.h1618","article-title":"Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials","volume":"350","author":"Navarese","year":"2015","journal-title":"BMJ"},{"key":"R86-20251204","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1253\/circj.CJ-19-1109","article-title":"JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease","volume":"84","author":"Nakamura","year":"2020","journal-title":"Circ J"},{"key":"R87-20251204","doi-asserted-by":"crossref","first-page":"255263","DOI":"10.1007\/s12928-022-00847-1","article-title":"Antiplatelet therapy after percutaneous coronary intervention: current status and future perspectives","volume":"37","author":"Natsuaki","year":"2022","journal-title":"Cardiovasc Interv Ther"},{"key":"R88-20251204","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1159\/000517051","article-title":"Is there an optimal antiplatelet strategy after gastrointestinal bleeding in patients with coronary artery disease?","volume":"146","author":"Pickett","year":"2021","journal-title":"Cardiology"},{"key":"R90-20251204","first-page":"1","article-title":"On behalf of the European Helicobacter and microbiota study group \u2013 management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"key":"R91-20251204","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jacc.2010.09.010","article-title":"ACCF\/ACG\/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use","volume":"56","author":"Abraham","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R92-20251204","doi-asserted-by":"crossref","first-page":"2985435","DOI":"10.1155\/2020\/2985435","article-title":"Percutaneous coronary intervention complexity and risk of adverse events in relation to high bleeding risk among patients receiving drug-eluting stents: insights from a large single-center cohort study","volume":"2020","author":"Wang","year":"2020","journal-title":"J Interv Cardiol"},{"key":"R93-20251204","doi-asserted-by":"crossref","first-page":"e13102","DOI":"10.1111\/eci.13102","article-title":"Platelet reactivity patterns in patients treated with dual antiplatelet therapy","volume":"49","author":"Winter","year":"2019","journal-title":"Eur J Clin Invest"},{"key":"R94-20251204","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/eurheartj\/eht042","article-title":"ESC working group on cardiovascular pharmacology and drug therapy and ESC working group on thrombosis. expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy","volume":"34","author":"Agerwall","year":"2013","journal-title":"Eur Heart J"},{"key":"R95-20251204","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1056\/NEJMoa065703","article-title":"Omeprazole before endoscopy in patients with gastrointestinal bleeding","volume":"356","author":"Lau","year":"2007","journal-title":"N Engl J Med"},{"issue":"3","key":"R96-20251204","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa042087","article-title":"Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding","volume":"352","author":"Chan","year":"2005","journal-title":"N Engl J Med"},{"key":"R97-20251204","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2169\/internalmedicine.48.2031","article-title":"Upper gastrointestinal bleeding in patients receiving dual antiplatelet therapy after coronary stenting","volume":"48","author":"Yasuda","year":"2009","journal-title":"Intern Med"},{"key":"R98-20251204","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1161\/CIRCULATIONAHA.109.873497","article-title":"Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome","volume":"120","author":"Rassen","year":"2009","journal-title":"Circulation"},{"key":"R99-20251204","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1160\/TH09-11-0800","article-title":"Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitors","volume":"104","author":"Sarafoff","year":"2010","journal-title":"Thromb Haemost"},{"key":"R100-20251204","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1160\/TH10-04-0218","article-title":"Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation","volume":"104","author":"Tentzeris","year":"2010","journal-title":"Thromb Haemost"},{"key":"R101-20251204","doi-asserted-by":"crossref","first-page":"S739","DOI":"10.1016\/S0016-5085(14)62678-0","article-title":"TAK-438 versus lansoprazole 15 mg for secondary prevention of peptic ulcers associated with low dose aspirin therapy: results of a phase 3 trial","volume":"146","author":"Kawai","year":"2014","journal-title":"Gastroenterol"},{"key":"R102-20251204","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00535-008-2215-4","article-title":"Management and outcome of peptic ulcers or erosions in patients receiving a combination of aspirin plus clopidogrel","volume":"43","author":"Ng","year":"2008","journal-title":"J Gastroenterol"},{"key":"R103-20251204","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00535-013-0839-5","article-title":"Risk factor profiles, drug usage, and prevalence of aspirin associated gastroduodenal injuries among high risk cardiovascular Japanese patients: the results from the MAGIC study","volume":"49","author":"Umemura","year":"2014","journal-title":"J Gastroenterol"},{"key":"R104-20251204","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/gutjnl-2017-314852","article-title":"Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study","volume":"67","author":"Kawai","year":"2018","journal-title":"Gut"},{"key":"R105-20251204","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00392-018-1392-2","article-title":"Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry","volume":"108","author":"Moalem","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"R106-20251204","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacc.2007.06.064","article-title":"Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study","volume":"51","author":"Gilard","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R107-20251204","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jama.2009.261","article-title":"Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome","volume":"301","author":"Ho","year":"2009","journal-title":"JAMA"},{"key":"R108-20251204","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00228-014-1710-1","article-title":"Prasugrel but not high dose clopidogrel overcomes the lansoprazole neutralizing effect of P2Y12 inhibition: results of the randomized DOSAPI study","volume":"70","author":"Collet","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"R109-20251204","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJMoa1205512","article-title":"Prasugrel versus clopidogrel for acute coronary syndromes without revascularization","volume":"367","author":"Roe","year":"2012","journal-title":"N Engl J Med"},{"key":"R110-20251204","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.jacc.2010.03.100","article-title":"Inhibitory effects of ticagrelor compared to clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO PLATELET substudy","volume":"56","author":"Storey","year":"2010","journal-title":"J Am Coll Cardiol"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000002833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T08:06:21Z","timestamp":1764835581000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000002833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":108,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000002833","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"2024-09-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}